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ORIGINAL CONTRIBUTION
Fibrin Glue Eliminates the Need For Packing
After Complex Liver Injuries
Ara J. Feinstein, J. Esteban Varela, Stephen M. Cohna, Raymond
P Compton, and Mark G. McKenney
Department ofSurgery, Division of Trauma and Surgical Critical Care,
University ofMiami School ofMedicine
Hemostasis after traumatic liver injury can be extremely difficult to obtain, particularly in coagu-
lopathic patients who have suffered extensive liver damage. We determined the ability ofafibrin
gluepreparation (FG) to terminate ongoing bleeding using a new, clinically relevantporcine model
ofcomplex hepatic injury. Anesthetized swine (n = 6, 18 to 19 kg) received an external blast to the
right upper abdomen and were immediately anticoagulated with intravenous heparin (200 u/kg).
Uncontrolled hemorrhagefrom blast continuedfrom time ofinjury (t = 0 minutes) to t = 15 min-
utes. Lactated Ringer's solution was infused to keep mean arterial pressure (MAP) > 80 mm Hg
until the end ofexperiment (t = 90minutes). Animals underwent routine surgical techniques to con-
trol bleeding, and FG was employed in the event these measuresfailed. Estimated blood loss and
fluid resuscitation volume were measured. Serial MAP, arterial base excess, and temperature were
recorded. Animals were severely injured with significant blood loss prior to laparotomy (26 ± 6
cc/kg) and during routine surgical efforts to arrest hemorrhage (11 ± 2 cc/kg). Bleeding could not
be controlled with standard techniques in any animal. FG rapidly controlledhemorrhage andelim-
inated the needforpacking. Re-bleeding was noted in only one animal (portal vein injury). FG can
control severe hepatic hemorrhage when surgicaltechniquesfaiL Furtherwork in the clinical arena
is warranted to determine thepotential benefits ofFG in arresting hemorrhage in hemodynamical-
ly unstable coagulopathicpatients with complex hepatic injuries.
INTRODUCTION
Liver injuries have an associated mor-
tality of approximately 25 percent with
exsanguination being the primary cause of
death [1, 2]. Hemostasis in these patients
is hindered by the development of coagu-
lopathy, which results from hypothermia,
dilution of clotting factors, and thrombo-
cytopenia. Control of bleeding in severe
liver injuries frequently requires packing,
with definitive repair delayed for hours
while the coagulopathy is corrected [3].
New methods forobtaining rapid hemosta-
sis in this setting would obviate the need
for second-look procedures and represent
a significant addition to the surgeon's
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armamentarium. Fibrin glue (FG)b has
been effective in arresting hemorrhage in
animal models of hepatic injury [4-7].
Unfortunately, current recipes for FG
preparations have required either the use
of pooled coagulation factors carrying the
associated risk for viral disease transmis-
sion, or involve time consuming autolo-
gous extraction techniques which are not
easily applicable to the trauma setting [8].
Purified FGs, which are free of viral cont-
amination, are now available and can be
stored in a refrigerator in the operating
room and rapidly reconstituted. This tech-
nical advance represents a potential mile-
stone for the use of FG in trauma victims.
We hypothesized that the use of a new,
viral-free FG would eliminate the need for
packing in the setting of uncontrollable
bleeding in a porcine liver injury model.
METHODS
The experimental protocol was
approved by the University of Miami,
School ofMedicine, Animal Care and Use
Committee and metthe NIH guidelines for
animal use.
Male Yorkshire random-bred male
pigs (n = 6, 18 to 19 kg) were sedated with
intramuscular ketamine (10 mg/kg) and
anesthetized with intravenous sodium pen-
tobarbital (10 mg/kg). Animals were oro-
tracheally intubated and ventilated
(Ventilator Harvard Apparatus, South
Natick, Massachusetts); FiO2 1.0; tidal
volume 10 cc/kg; respiratory rate was
adjusted to maintain arterial pCO2 at 40 +
5 torr. Femoral arterial and venous
catheters were placed for hemodynamic
monitoring, fluid resuscitation, and anes-
thetic infusion. Mean systemic arterial
pressure (MAP) and pulse were continu-
ously recorded by an amplifier-monitor
(Datascope 2000A, Paramus, New Jersey).
Arterial blood gases (Ciba Corning 238
pH/Blood Gas Analyzer, Medfield,
Massachusetts) and arterial hemoglobin
saturation (SaO2) (Palco Pulsoximeter
model 340, Santa Cruz, California) were
measured. After completion of surgical
procedures, general anesthesia was main-
tained with a continuous infusion of sodi-
um pentobarbital (17 mg/kg/hr). Rectal
temperature was serially measured.
Heating pads were turned off at the
moment of injury.
Liver injury methodology
After a 15-minute equilibration peri-
od, a liver injury was induced. A nail dri-
ver (Ramset/Red Head, Low Velocity
Piston Type Fastening Tool, Model 4170,
Wood Dale, Illinois) with a 22 caliber
charge (Pneutek, Inc., A22ND-2 low
velocity, power load, Hudson, New
Hampshire) was fired onto a solid alu-
minum disk (5 cm diameter, 1 cm thick). It
was taped halfway between the xyphoid
process and the anterior axillary line
below the costal margin. This technique
was adapted from one previously
described [9]. At full inspiration, the endo-
tracheal tube was clamped prior to induc-
ing the external blast to the abdominal
wall that generated the Grade III liver lac-
eration, which resembles the clinical sce-
nario (t = 0 minutes). Injuries were repro-
ducible, inducing an area of deep contu-
sion, 4 to 6 cm in diameter, stellate in
shape, between segments IV and V of
liver. Immediately after the contusion, the
animals were anticoagulated with intra-
venous bovine heparin (200 units/kg).
After a 5 minute period, resuscitation was
begun using Lactated Ringer's (LR) solu-
tion at 20 cc/kg infused over 10 minutes (t
= 5 to t = 15 minutes). At t = 15 minutes,
laparotomy was performed to control hem-
orrhage. Free intraperitoneal blood was
determined by change in the weight oflap
pads. Estimated blood loss was deter-
mined using the following formula: cc of
blood = (wet-dry lap pads) gm/1.043. The
degree of liver injury was assessed.
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hepatic repair including Pringle maneuver
for no more than 10 minutes when uti-
lized, deep liver suture, electrocautery,
local tamponade, and hemostatic agents
(SURGICEL-, Johnson and Johnson,
Arlington, Texas). Blood loss during
repair using these standard techniques was
measured. Ten minutes after the start of
laparotomy (t = 25 minutes) ifthe surgeon
determined that bleeding was not con-
trolled, FG was made available. The FG,
consisting of human topical fibrinogen
complex, human thrombin, and calcium
chloride, was constituted just prior to
celiotomy. Kits containing the FG (Two-
Component Fibrin Sealant Kit Vapor
Heated, Immuno-US Inc, Rochester,
Michigan) were removed from refrigerator
at 4°C and warmed to 37°C. The fibrino-
gen complex (human sealer protein con-
centrate) and fibrinolysis inhibitor were
mixed and drawn into a 2 cc syringe. The
human thrombin was reconstituted using
calcium chloride and drawn into a second
2 cc syringe. The two syringes were
loaded into a y-shaped single-port inject-
ing device for application. The product
was readied in 10 to 15 minutes prior to
application, and each application totaled
approximately 3 ml, with a maximum of
three kits utilized per pig. The glue was
applied to the edge ofthe liverandbrought
into proximity as it was compressed until
there was no actual hemorrhage and then
sealed. If there was active hemorrhage
after the full application, the surgeon
would then pack all bleeding areas with
lap pads. The abdomen was closed 15
minutes after initiating FG repair (t = 40
minutes). After laparotomy, maintenance
fluids (LR) were continued until the end of
the experiment to maintain MAP greater
than 80 mm Hg. Ninety minutes after
injury, re-laparotomy was performed to
determine evidence of rebleeding and the
animals euthanized with intravenous
euthanasia solution (sodium pentobarbital,
sodium phenytoin), 10mg/kg.
Statistical analysis
Statistical analysis was performed
using a statistical software package
(Statistica, Statsoft Inc., Tulsa,
Oklahoma). Groups were compared by
analysis of variance (ANOVA) with post
hoc comparisons (Tukey's HSD test).
Differences were considered statistically
significant when p < .05
RESULTS
Mean animal weight for six swine
was 18.6 kg (range 18 to 19 kg). There
were no differences noted in heart rate in
the group at baseline compared to end of
experiment. The liver injury did result in a
significant decrease in MAP in the group
following laparotomy with attempted sur-
gical hemostasis . A significant decrease in
body temperature occurred (38 ± .4 vs. 34
± .3°C) between t = 0 and the end of the
experiment. A significant decrease in arte-
rial base deficit was also noted after injury
(See Table 1.).
Table 1.
Time T=0 T=5 T=15 T=25 T=40 T=60 T=75 T=90
P(beats/min) 160 ±5 190±10 158±8 161±8 150±7 148±5 150±7 152±7
MAP(mm/Hg) 95±7 69±6 78±3 54±5* 70±3* 69±3* 69±3* 63±3*
Time (°C) 38 ±.4 38± .4 38± .3 37 ±.2 36±.3* 35 ±.3* 35 ±.4* 34±.3*
ABE (mEq/L) -4 ± 1 -5 ± 2 -6 ± 1 -7 ±.9 -10 ± 1 -11 ± 1 -11 ± 1 -11 ± 2
Table 1 lists results of hemorrhage study. P, pulse; MAP, mean arterial pressure, ABE, arterial base
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The animals were severely injured in
this model with significantblood loss prior
to laparotomy (26 ± 6 cc/kg) and during
routine surgical techniques from t = 15 to
t = 25 minutes (11 ± 2 cc/kg) with signifi-
cant fluid required during this initial resus-
citation, t = 5 to t = 15 minutes (LR: 33 ±
9 cc/kg). Bleeding could not be controlled
with routine hemostatic techniques in any
animal. FG rapidly controlled hemorrhage
and no animals needed to be packed. Re-
bleeding was noted in one animal. (This
was due to an unrecognized portal vein
injury, which appeared to be controlled
initially with FG application.)
DISCUSSION
The principal findings of this study
were: 1) FG terminated hemorrhage which
was not controllable with conventional
surgical techniques. 2) FG-treated animals
did not require packing for their complex
hepatic injuries in our model.
At the turn of the century, surgeons
first experimented with hemostatic materi-
als to arrest hemorrhage from vital organs.
In 1911, Cushing used fragments of raw
muscle and solidified blood clots for
hemostasis without adverse effects [10].
At Cushing's suggestion, Grey performed
experiments with fibrin extracted from
sheep's blood to control bleeding from
skin and cerebral lacerations in cats and
dogs [11]. Harvey converted bovine fibrin
into a paper-like hemostatic material,
which he used in wound repair and intesti-
nal anastomoses [12]. FG was firstusedby
plastic surgeons in nerve anastomoses
more than 50 years ago [13]. In 1944,
Cronkite reported the use ofthrombin and
fibrinogen together as skin grafting agents
in amanner similar to the presentday [14].
FG was "re-discovered" in the 1970s with
the development of microsurgical tech-
niques. During the past two decades, FG
has been used increasingly as a sealant or
hemostatic agent in many areas of surgery
[8].
The mechanism of action of FG
involves the stimulation ofnatural clotting
factors (Figure 1). FG is formed by multi-
ple components such as fibrinogen, factor
XIIIa, thrombin, calcium chloride and
aprotinin. Fibrinogen is converted to fibrin
by thrombin; and fibrin molecules poly-
merize in the presence ofcalcium and fac-
tor XIII to form a stable fibrin clot. FG is
eventually metabolized without residue
[6].
Experimental work has supported the
notion that FG is beneficial in arresting
hemorrhage from visceral injury. Jakob
andhis group were among thefirst to show
fibrin sealant to be beneficial in arresting
hemorrhage during hepatic injury [5]. In
anticoagulated rats with liverdamage, they
demonstrated an improvement in survival
when conventional suture repair tech-
niques were compared with fibrin impreg-
nated collagen. The fibrin sealant was
completely absorbed without foreign body
reaction or fibrosis at 28 days [5]. Kram
and colleagues evaluated the efficacy of
FG in superficial anddeep liverlacerations
[6]. Twelve adult dogs were anesthetized
and underwent laparotomy followed by
formation ofa significant hepatic injury or
Trombin Factor Xa, Ca+
Hbrinogen lbR nMonan Fbrin Momemir Jijilj Polymer
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lobar resection. After noting brisk bleed-
ing, FG was applied. Effective hemostasis
and good local and systemic compatibility
were observed. Histologic examination of
the liverperformed at 12 and 24 hours and
at two, three, six, and eight weeks revealed
no gross evidence of hepatic disruption,
hematoma formation or recurrent bleed-
ing. By four to six weeks, the FG was
absorbed and the underlying hepatic
parenchyma appeared well regenerated.
Dulchavsky et al. found fibrin sealant to be
protective in a murine model of contami-
nated hepatic injury [4]. Anesthetized rats
received a liver laceration via laparotomy,
and the peritoneum was inoculated with
Bacillusfragilis. Animals treated with FG
had decreased abscess formation and
fewer adhesions when compared to routine
hepatorrhaphy. In earlier work, we showed
that another FG product (Baxter
Pharmaceuticals, Hyland Division, Los
Angeles, California), statistically signifi-
cantly reduced the operative blood loss
associated with a severe liver injury when
a group of animals receiving FG were
compared to those receiving standard sur-
gical methods only [7]. Pigs receiving
standard methods required packing in six
of seven animals, while none of FG treat-
ed animals (seven ofseven) required pack-
ing. Estimated blood loss was 875 ± 265
cc in the control group and decreased sig-
nificantly to 300 ± 59 cc in the FG treated
animals.
In recent studies, Holcomb et al. has
shown that a fibrin-based foam could
reduce blood loss compared to a placebo
foam in a murine model where the median
hepatic lobe was excised [15]. This group
also studied a porcine model of Grade V
liver injury using a clamping technique to
induce the lesion. The initial study showed
a 51 percent decrease in the amount of
blood loss with a dry fibrin sealant dress-
ing (DFSD) over standard packing [16].
These results, however, did not reach sta-
tistical significance. A follow-up study
using a similar model showed a one-hour
survival of 83 percent in the DFSD group
and 0 percent in routine packing and
placebo groups [17].
FG may have particular clinical utility
in the setting ofabdominal trauma [8], but
there is limited data on FG utility in liver
injury. Kram et al. reported successful
repair with FG after hepatic injury in eight
coagulopathic patients [18]. Ochsner and
coworkers had similar success with hepat-
ic and splenic hemostasis after trauma in
eight coagulopathic patients [19]. Recent
case reports have attributed hypotensive
episodes during intraparenchymal injec-
tion in deep liver injuries to FG [20, 21].
These adverse reactions were thought to
be secondary to intravascular injection of
FG prepared with bovine thrombin, how-
ever, these secondary effects were not
reported with this new human thrombin
product. The studies above represent the
sum of animal and clinical research
regarding the use of FG in the setting of
hepatic hemorrhage.
Our investigation examined the
impact of FG upon hemostasis in a model
of uncontrolled hemorrhage from liver
injury. This model of liver contusion
grossly resembles the clinical entity and is
similar to one used in our previous study
[7]. The use of a porcine model is advan-
tageous because of the similar hepatic
anatomy and large animal size that allows
use of instruments and techniques from
clinical practice. This study differs from
the previous one in several ways. Itutilizes
a newer, FDA approved viral-free FG
preparation increasing the clinical rele-
vance of the experiment. In our previous
study, control pigs were injured and
received only conventional treatment. This
resulted in a high mortality during the
course of the experiment for the control
group. In the current study, animals acted
as their own controls.
There are several limitations to the
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simulate a patient's course following a
blunt hepatic injury, anesthetizing the ani-
mals was necessary to allow for comple-
tion ofall ofthe procedures outlined in our
protocol. The dose ofpentobarbital used in
the study was determined from previous
experiments [7, 9] and reflects the mini-
mal amount needed to keep the animals
sedated throughout the experiment. This
may have contributed to the drop in MAP
after injury and high resuscitation vol-
umes, but the animals were allowed to
equilibrate under anesthesia without any
manipulation for 15 minutes before injury.
Second, in order to replicate the coagu-
lopathy that individuals experience as a
result ofremaining in the field for extend-
ed periods oftime, all of the pigs received
a large dose of intravenous heparin.
Heparin was given to increase blood loss
as well as make the animals less likely to
respond to either packing or FG. The
supra-therapeutic dose of heparin induces
a severe coagulopathy in excess of that
necessary for clinical anticoagulation.
Although hypothermia was not severe
enough to induce a coagulation dysfunc-
tion, there are significant numbers of
patients on anticoagulant medication or
having an underlying high degree of liver
dysfunction that place them in an antico-
agulation state. Third, despite our attempts
to create a hepatic injury of a specific size
and depth, the differences in respective
anatomies of the pigs prevented perfectly
reproducible contusions between animals.
One pig sustained a portal vein injury,
which was unrecognized and bled mas-
sively following laparotomy. Also, the
nature of the injuries was such that they
required emergent repair during the
laparotomy and precluded any precise
measurement of the size of the contused
area.
Fourth, comparison of blood loss and
resuscitation requirements after injury was
limited by the techniques used and vari-
ability among animals. The use oflap pads
to measure blood loss, while not precise,
allows comparison of initial hemorrhage
volumes among the animals. The amount
of blood at re-laparotomy in all but one
animal was negligible. Our fixed volume
resuscitation of 20 cc/kg may have been
excessive but reflects an amount routinely
used in trauma patients. The decision was
made to maintain MAP greater than 80
mmHg in an attempt to replicate the typi-
cal clinical scenario.
In a heparinized porcine model of
complex hepatic injury, FG controlled
hemoffhage after failure of conventional
surgical techniques. FG quickly estab-
lished a hemostatic seal over the bleeding
areas. Most importantly, the use ofFGper-
mitted safe completion of the abdominal
operation without the need for packing of
parenchymal injuries. Further work in the
clinical arena is warranted to determine
the potential benefits of FG in arresting
hemorrhage in the coagulopathic trauma
patient with complex hepatic injuries.
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